Yuntao Xie

5.3k total citations
164 papers, 3.7k citations indexed

About

Yuntao Xie is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Yuntao Xie has authored 164 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 70 papers in Cancer Research and 64 papers in Molecular Biology. Recurrent topics in Yuntao Xie's work include Breast Cancer Treatment Studies (50 papers), BRCA gene mutations in cancer (40 papers) and Breast Lesions and Carcinomas (27 papers). Yuntao Xie is often cited by papers focused on Breast Cancer Treatment Studies (50 papers), BRCA gene mutations in cancer (40 papers) and Breast Lesions and Carcinomas (27 papers). Yuntao Xie collaborates with scholars based in China, Ethiopia and Sweden. Yuntao Xie's co-authors include Zhaoqing Fan, Benyao Lin, Tie Fan, Jinfeng Li, Ye Xu, Tao Ouyang, Aiqin Wang, Olle Larsson, Tianfeng Wang and Tao Ouyang and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Yuntao Xie

159 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuntao Xie China 35 1.7k 1.2k 1.2k 911 632 164 3.7k
Ping Sun China 31 1.3k 0.8× 680 0.6× 945 0.8× 565 0.6× 283 0.4× 170 3.4k
Weizhou Zhang United States 37 2.8k 1.6× 1.8k 1.4× 1.1k 0.9× 224 0.2× 471 0.7× 111 5.1k
Andreas Evdokiou Australia 40 2.1k 1.2× 1.4k 1.2× 563 0.5× 295 0.3× 512 0.8× 100 4.2k
Gayathri R. Devi United States 37 2.2k 1.3× 1.5k 1.3× 791 0.7× 345 0.4× 323 0.5× 96 4.3k
Masanobu Shindoh Japan 43 2.9k 1.7× 1.6k 1.3× 1.5k 1.3× 253 0.3× 625 1.0× 165 5.3k
Xuesong Gu United States 34 2.8k 1.6× 1.0k 0.8× 642 0.6× 241 0.3× 472 0.7× 74 4.3k
Manohar Ratnam United States 31 2.8k 1.7× 1.1k 0.9× 395 0.3× 425 0.5× 606 1.0× 103 5.5k
Ying Zhu China 34 1.5k 0.9× 754 0.6× 897 0.8× 239 0.3× 379 0.6× 145 3.4k
Qing‐Xiang Amy Sang United States 43 2.4k 1.4× 2.0k 1.6× 2.7k 2.3× 328 0.4× 491 0.8× 123 6.0k
Lisong Teng China 33 1.4k 0.8× 968 0.8× 758 0.7× 181 0.2× 655 1.0× 170 3.7k

Countries citing papers authored by Yuntao Xie

Since Specialization
Citations

This map shows the geographic impact of Yuntao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuntao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuntao Xie more than expected).

Fields of papers citing papers by Yuntao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuntao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuntao Xie. The network helps show where Yuntao Xie may publish in the future.

Co-authorship network of co-authors of Yuntao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yuntao Xie. A scholar is included among the top collaborators of Yuntao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuntao Xie. Yuntao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Wei-lie, et al.. (2024). Hydromechanical behaviors of geogrids-reinforced expansive soil slopes: Case study and numerical simulation. Computers and Geotechnics. 174. 106626–106626. 3 indexed citations
2.
Wang, Xinguang, Qijun Zheng, Yingjian He, et al.. (2024). Diagnostic accuracy of sentinel lymph node biopsy and wire localized clipped node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. Surgery Today. 55(2). 172–179. 1 indexed citations
3.
Liu, Xuejing, Yanjie Wang, Kun Cao, et al.. (2023). Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants. Breast Cancer Research and Treatment. 199(1). 25–33. 3 indexed citations
4.
Wang, Xinguang, Zhaoqing Fan, Xing Wang, et al.. (2022). Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study. Breast Cancer Research and Treatment. 195(3). 301–310. 8 indexed citations
5.
6.
Su, Liming, Tao Ouyang, Jinfeng Li, et al.. (2021). Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers. Cancer Research. 81(10). 2600–2611. 48 indexed citations
7.
Xu, Ye, Lu Yao, Tao Ouyang, et al.. (2019). Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. International Journal of Cancer. 146(2). 487–495. 17 indexed citations
8.
Ouyang, Tao, et al.. (2018). Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers. Annals of Oncology. 29(10). 2046–2051. 24 indexed citations
9.
Cao, Wei, Yingjian He, Jinfeng Li, et al.. (2018). Impact of adjuvant chemotherapy on the survival of patients with estrogen receptor≥50%, human epidermal growth factor receptor-2 negative, lymph node negative breast cancer. Zhonghua putong waike zazhi. 33(3). 223–227. 1 indexed citations
10.
Sun, Jie, Hua Meng, Lu Yao, et al.. (2017). Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients. Clinical Cancer Research. 23(20). 6113–6119. 145 indexed citations
11.
Zhang, Hong, Linsen Li, Yuxia Wang, et al.. (2017). Functional analysis of BRCT missense mutations in BRCA1‑mutated Chinese Han familial breast cancer. Oncology Letters. 14(5). 5839–5844. 2 indexed citations
12.
Yuan, Hua, Yiqiang Liu, Tao Ouyang, et al.. (2015). Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer. Clinical Cancer Research. 21(19). 4365–4372. 25 indexed citations
13.
Zhang, Lianhai, Xiaojiang Wu, Ying Hu, et al.. (2015). Establishment of a Network-Based Intra-Hospital Virtual Cancer Biobank. Biopreservation and Biobanking. 13(1). 43–48. 4 indexed citations
14.
Ouyang, Tao, Tianfeng Wang, Yuntao Xie, et al.. (2014). [The study of associations between circulating tumor cells and clinicopathologic characteristics in axillary lymph node positive primary breast cancer].. PubMed. 52(6). 420–4. 2 indexed citations
15.
Xu, Ye, Tao Ouyang, Zhaoqing Fan, et al.. (2014). Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer. Annals of Oncology. 25(6). 1158–1164. 37 indexed citations
16.
He, Yingjian, Yiqiang Liu, Zhaoqing Fan, et al.. (2013). [Analysis of associations between molecular subtypes and responses to neoadjuvant chemotherapy in primary breast cancer patients].. PubMed. 93(22). 1711–5. 2 indexed citations
17.
18.
Liu, Yin, Ji Liao, Ye Xu, et al.. (2011). A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women. Human Mutation. 32(9). 1000–1003. 22 indexed citations
19.
Ouyang, Tao, Tianfeng Wang, Yuntao Xie, et al.. (2010). [The clinical research of local recurrence after breast-conserving therapy for breast cancer].. PubMed. 48(24). 1851–4. 1 indexed citations
20.
Li, Hongxia, Ye Xu, Tao Ouyang, et al.. (2006). The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women. Acta Oncologica. 45(5). 597–601. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Sun Breakdown of academic impact, for papers by Weizhou Zhang Breakdown of academic impact, for papers by Andreas Evdokiou Breakdown of academic impact, for papers by Gayathri R. Devi Breakdown of academic impact, for papers by Masanobu Shindoh Breakdown of academic impact, for papers by Xuesong Gu Breakdown of academic impact, for papers by Manohar Ratnam Breakdown of academic impact, for papers by Ying Zhu Breakdown of academic impact, for papers by Qing‐Xiang Amy Sang Breakdown of academic impact, for papers by Lisong Teng
Rankless by CCL
2026